These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7713766)

  • 21. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative simultaneous cisplatin- or carboplatin-based chemotherapy and radiotherapy for squamous cell carcinoma of the oral cavity.
    Kirita T; Ohgi K; Tsuyuki M; Kamikaido N; Yamamoto K; Sugimura M
    J Surg Oncol; 1996 Dec; 63(4):240-8. PubMed ID: 8982368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant therapy for organ preservation in head and neck cancer.
    Urba SG; Wolf GT; Bradford CR; Thornton AF; Eisbruch A; Terrell JE; Carpenter V; Miller T; Tang G; Strawderman M
    Laryngoscope; 2000 Dec; 110(12):2074-80. PubMed ID: 11129024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0).
    Deo SV; Bhutani M; Shukla NK; Raina V; Rath GK; Purkayasth J
    J Surg Oncol; 2003 Dec; 84(4):192-7. PubMed ID: 14756429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative paclitaxel, carboplatin, and radiation therapy in advanced head and neck cancer (stage III and IV).
    Wanebo HJ; Chougule P; Ready N; Koness RJ; Akerley W; McRae R; Nigri P; Leone L; Webber B; Safran H
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):77-84. PubMed ID: 10210544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer.
    Malone JP; Stephens JA; Grecula JC; Rhoades CA; Ghaheri BA; Schuller DE
    Head Neck; 2004 Jul; 26(7):561-72. PubMed ID: 15229898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative paclitaxel/carboplatin radiochemotherapy for stage III/IV resectable oral and oropharyngeal cancer: seven-year follow-up of a phase II trial.
    Eckardt A; Sinikovic B; Hofele C; Bremer M; Reuter C
    Oncology; 2007; 73(3-4):198-203. PubMed ID: 18424883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cancers of the base of the tongue and hypopharynx: results of a multicenter randomized trial of chemotherapy prior to locoregional treatment].
    Gedouin D; Desprez P; Perron JJ; Fleury F; Leclech G; Miglianico L; Belpomme D; Chenal C
    Bull Cancer Radiother; 1996; 83(2):104-7. PubMed ID: 8688215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative radiochemotherapy and radical resection for stages II-IV oral and oropharyngeal cancer: outcome of 222 patients.
    Klug C; Wutzl A; Kermer C; Voracek M; Kornek G; Selzer E; Glaser C; Poeschl PW; Millesi W; Ewers R
    Int J Oral Maxillofac Surg; 2005 Mar; 34(2):143-8. PubMed ID: 15695042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC).
    Domenge C; Hill C; Lefebvre JL; De Raucourt D; Rhein B; Wibault P; Marandas P; Coche-Dequeant B; Stromboni-Luboinski M; Sancho-Garnier H; Luboinski B;
    Br J Cancer; 2000 Dec; 83(12):1594-8. PubMed ID: 11189100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined chemotherapy and radiotherapy versus surgery and postoperative radiotherapy for advanced hypopharyngeal cancer.
    Zelefsky MJ; Kraus DH; Pfister DG; Raben A; Shah JP; Strong EW; Spiro RH; Bosl GJ; Harrison LB
    Head Neck; 1996; 18(5):405-11. PubMed ID: 8864731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Katori H; Tsukuda M; Watai K
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):399-406. PubMed ID: 17096160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Carboplatin and paclitaxel induction chemotherapy for patients with oropharynx carcinoma].
    Schneider I; Holzgraefe M; Schröder M
    Laryngorhinootologie; 2008 Oct; 87(10):719-22. PubMed ID: 18548405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neoadjuvant chemotherapy of stage IIb or III cancers of the uterine cervix. Long-term results of a multicenter randomized trial of 151 patients].
    Chauvergne J; Lhommé C; Rohart J; Héron JF; Ayme Y; Goupil A; Fargeot P; David M
    Bull Cancer; 1993 Dec; 80(12):1069-79. PubMed ID: 8081045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer.
    Prosnitz RG; Yao B; Farrell CL; Clough R; Brizel DM
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1087-95. PubMed ID: 15752888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative radiochemotherapy in the treatment of advanced oral cancer: outcome of 276 patients.
    Klug C; Berzaczy D; Voracek M; Nell C; Ploder O; Millesi W; Ewers R
    J Craniomaxillofac Surg; 2009 Sep; 37(6):344-7. PubMed ID: 19525119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concurrent paclitaxel, carboplatin, and radiotherapy in advanced head and neck cancers: a phase II study--preliminary results.
    Chougule P; Wanebo H; Akerley W; McRae R; Nigri P; Leone L; Safran H; Ready N; Koness RJ; Radie-Keane K; Cole B
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-57-S19-61. PubMed ID: 9427268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mature results from a randomized Phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable Stage IV head and neck squamous cell carcinomas.
    Le QT; Taira A; Budenz S; Jo Dorie M; Goffinet DR; Fee WE; Goode R; Bloch D; Koong A; Martin Brown J; Pinto HA
    Cancer; 2006 May; 106(9):1940-9. PubMed ID: 16532436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer.
    Semrau R; Mueller RP; Stuetzer H; Staar S; Schroeder U; Guntinas-Lichius O; Kocher M; Eich HT; Dietz A; Flentje M; Rudat V; Volling P; Schroeder M; Eckel HE
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1308-16. PubMed ID: 16464538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concurrent chemoradiation with carboplatin-5-fluorouracil versus cisplatin in locally advanced oropharyngeal cancers: is more always better?
    Barkati M; Fortin B; Soulières D; Clavel S; Després P; Charpentier D; Tabet JC; Guertin L; Olivier MJ; Coulombe G; Donath D; Nguyen-Tan PF
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):410-6. PubMed ID: 19427745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.